PharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical Industry
PharmaCord LLC (“PharmaCord”), a leading provider of patient services for the biopharmaceutical industry, and Mercalis, an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain, today announced a merger to create one of the largest and most trusted independent total solutions providers to the biopharmaceutical industry. The combined company will be an industry-leading provider that offers a full suite of solutions, from patient services to market access, supporting the entire commercialization process.
